Minerva Neurosciences (NERV) Tops Q2 EPS by 14c

Minerva Neurosciences (NASDAQ: NERV) reported Q2 EPS of ($0.27), $0.14 better than the analyst estimate of ($0.41).

For earnings history and earnings-related data on Minerva Neurosciences (NERV) click here.

You May Also Be Interested In

• Baird on Nurix (NRIX) Earnings Amid 7% Drop: '2Q Print Solid as Breadth of Development Expands'
• Piper Sandler on FirstSun Capital Bancorp (FSUN): 'We expect shares to underperform on Friday'
• Benchmark Reiterates Buy Rating on Penske Automotive Group (PAG)